Caregen Co., Ltd. (KOSDAQ:214370)
South Korea
· Delayed Price · Currency is KRW 25,600
+550 (2.20%)
Apr 1, 2025, 3:30 PM KST
Caregen Revenue
In the year 2024, Caregen had annual revenue of 82.59B KRW with 4.26% growth. Caregen had revenue of 21.36B in the quarter ending December 31, 2024, with 22.47% growth.
Revenue
82.59B
Revenue Growth
+4.26%
P/S Ratio
15.21
Revenue / Employee
458.81M
Employees
180
Market Cap
1,251.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
| Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
| Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
| Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
| Dec 31, 2020 | 60.30B | -4.40B | -6.81% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |
Caregen News
- 4 months ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 4 months ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn